Filing Flows › ExlService Holdings (EXLS) › Healthcare and Life Sciences revenue
ExlService Holdings (EXLS) Healthcare and Life Sciences revenue by quarter
ExlService Holdings' Healthcare and Life Sciences revenue was $161M in Q3 2026 (third quarter 2026), +2% from Q2 2026. Over the last 7 quarters it ranged from $126M (Q1 2025) to $161M (Q3 2026).
| Quarter | Healthcare and Life Sciences revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $161M | +2% | +19% |
| Q2 2026 | $158M | +4% | +22% |
| Q1 2026 | $152M | +7% | +21% |
| Q4 2025 | $142M | +5% | — |
| Q3 2025 | $136M | +4% | — |
| Q2 2025 | $130M | +3% | — |
| Q1 2025 | $126M | — | — |
Q3 2026 at a glance
ExlService Holdings, Q3 2026: revenue $634M (+20% year over year), operating margin 14.0%, net earnings $68.8M, operating cash flow $119M. The chart follows the revenue to costs, profit and cash.
Questions
What is ExlService Holdings' Healthcare and Life Sciences revenue?
ExlService Holdings' Healthcare and Life Sciences revenue was $161M in Q3 2026 (third quarter 2026), +2% from Q2 2026.
How has ExlService Holdings' Healthcare and Life Sciences revenue changed?
Over the last 7 quarters it ranged from $126M (Q1 2025) to $161M (Q3 2026).